Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Turcotte M, Allard D, Mittal D, Bareche Y, Buisseret L, José V, Pommey S, Delisle V, Loi S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Smyth MJ, Stagg J. Turcotte M, et al. Among authors: joensuu h. Cancer Res. 2017 Oct 15;77(20):5652-5663. doi: 10.1158/0008-5472.CAN-17-0707. Epub 2017 Aug 30. Cancer Res. 2017. PMID: 28855210
Intermittent interferon and polychemotherapy in metastatic melanoma.
Vuoristo MS, Gröhn P, Kellokumpu-Lehtinen P, Kumpulainen E, Turunen M, Korpela M, Joensuu H, Tiusanen K, Nevantaus A. Vuoristo MS, et al. Among authors: joensuu h. J Cancer Res Clin Oncol. 1995;121(3):175-80. doi: 10.1007/BF01198100. J Cancer Res Clin Oncol. 1995. PMID: 7536196 Clinical Trial.
Late mortality from pT1N0M0 breast carcinoma.
Joensuu H, Pylkkänen L, Toikkanen S. Joensuu H, et al. Cancer. 1999 May 15;85(10):2183-9. doi: 10.1002/(sici)1097-0142(19990515)85:10<2183::aid-cncr12>3.0.co;2-k. Cancer. 1999. PMID: 10326696
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
Joensuu H, Kellokumpu-Lehtinen PL, Bono P, Alanko T, Kataja V, Asola R, Utriainen T, Kokko R, Hemminki A, Tarkkanen M, Turpeenniemi-Hujanen T, Jyrkkiö S, Flander M, Helle L, Ingalsuo S, Johansson K, Jääskeläinen AS, Pajunen M, Rauhala M, Kaleva-Kerola J, Salminen T, Leinonen M, Elomaa I, Isola J; FinHer Study Investigators. Joensuu H, et al. N Engl J Med. 2006 Feb 23;354(8):809-20. doi: 10.1056/NEJMoa053028. N Engl J Med. 2006. PMID: 16495393 Free article. Clinical Trial.
A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes.
Kellokumpu-Lehtinen PL, Sunela K, Lehtinen I, Joensuu H, Sjöström-Mattson J; Finnish Breast Cancer Group. Kellokumpu-Lehtinen PL, et al. Among authors: joensuu h. Clin Breast Cancer. 2006 Dec;7(5):401-5. doi: 10.3816/cbc.2006.n.057. Clin Breast Cancer. 2006. PMID: 17239265 Clinical Trial.
Association of Wwox with ErbB4 in breast cancer.
Aqeilan RI, Donati V, Gaudio E, Nicoloso MS, Sundvall M, Korhonen A, Lundin J, Isola J, Sudol M, Joensuu H, Croce CM, Elenius K. Aqeilan RI, et al. Among authors: joensuu h. Cancer Res. 2007 Oct 1;67(19):9330-6. doi: 10.1158/0008-5472.CAN-07-2147. Cancer Res. 2007. PMID: 17909041
620 results